Achieve Life Sciences Inc. (NASDAQ: ACHV)
$4.94
+0.1100 ( +2.28% ) 124.4K
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Market Data
Open
$4.94
Previous close
$4.83
Volume
124.4K
Market cap
$169.99M
Day range
$4.86 - $5.01
52 week range
$3.03 - $5.98
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 89 | Mar 28, 2024 |
8-k | 8K-related | 13 | Mar 28, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
8-k | 8K-related | 17 | Feb 29, 2024 |
4 | Insider transactions | 1 | Jan 29, 2024 |
4 | Insider transactions | 1 | Jan 24, 2024 |
4 | Insider transactions | 1 | Jan 24, 2024 |
4 | Insider transactions | 1 | Jan 24, 2024 |
4 | Insider transactions | 1 | Jan 24, 2024 |